SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001552781-13-000068
Filing Date
2013-11-13
Accepted
2013-11-13 14:38:29
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 nanoantibiotics_10q.htm 10-Q 347916
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 ex_31-1.htm EX-31.1 11399
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S. C. SECTION 1350 ex_32-1.htm EX-32.1 4949
  Complete submission text file 0001552781-13-000068.txt   1228594

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nati-20130930.xml EX-101.INS 110701
5 XBRL SCHEMA FILE nati-20130930.xsd EX-101.SCH 14957
6 XBRL CALCULATION FILE nati-20130930_cal.xml EX-101.CAL 6991
7 XBRL DEFINITION FILE nati-20130930_def.xml EX-101.DEF 12648
8 XBRL LABEL FILE nati-20130930_lab.xml EX-101.LAB 75813
9 XBRL PRESENTATION FILE nati-20130930_pre.xml EX-101.PRE 52602
Mailing Address 9511 COLLINS AVENUE SUITE 807 SURFSIDE FL 33154
Business Address 9511 COLLINS AVENUE SUITE 807 SURFSIDE FL 33154 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-190635 | Film No.: 131214047
SIC: 2834 Pharmaceutical Preparations